Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | DAO | P14920 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | FLT3 | P36888 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.50 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27254679 | 1.00 | KDM4E (0.60) | KDM4EMAPTDAOHPGDSRD5A2 | |
| SCHEMBL24896473 | 0.85 | AR (0.49) | KDM4EMAPTHPGDFLT3NPC1 | |
| SCHEMBL9410532 | 0.85 | SMAD3 (0.59) | FLT3PDGFRBPDGFRAPYGL | |
| SCHEMBL27254461 | 0.84 | PYGL (0.52) | FLT3IDO1NPC1PYGL | |
| SCHEMBL24896475 | 0.84 | ATM (0.57) | KDM4EMAPTHPGDHSD17B10FLT3 | |
| SCHEMBL4001756 | 0.84 | KDM4E (0.55) | KDM4EMAPTDAOHPGDSRD5A2 | |
| SCHEMBL378260 | 0.83 | FLT3 (0.65) | KDM4EMAPTDAOHPGDSRD5A2 | |
| SCHEMBL29595772 | 0.83 | FLT3 (0.65) | KDM4EMAPTDAOHPGDSRD5A2 | |
| SCHEMBL9410549 | 0.82 | MEN1 (0.64) | KDM4EMAPTHPGDFLT3LMNA | |
| Hydrochloric Acid SCHEMBL35211567 | 0.82 | FLT3 (0.62) | KDM4EMAPTDAOHPGDSRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638421-A1 | PROCESS TO MAKE GLP1 RA AND INTERMEDIATES THEREFOR | Eli Lilly and Company (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250092041-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-03-20 | — | — | US | disclosed |
| WO-2024137426-A1 | PROCESS TO MAKE GLP1 RA AND INTERMEDIATES THEREFOR | ELI LILLY AND COMPANY (US) | 2024-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092041-A1 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | GLP1R, GPR119, GIPR | KDM4E 1278/4885MAPT 4437/4885DAO 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.